Literature DB >> 1773944

Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?

R W Chapman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1773944      PMCID： PMC1379237          DOI： 10.1136/gut.32.12.1433

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  39 in total

1.  BILE ACIDS, CIRRHOSIS, AND HUMAN EVOLUTION.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1964-04       Impact factor: 22.682

2.  PERICHOLANGITIS AND ULCERATIVE COLITIS. II. CLINICAL ASPECTS.

Authors:  S P MISTILIS; A P SKYRING; S J GOULSTON
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

3.  Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  G Y Minuk; N Rascanin; R W Paul; P W Lee; K Buchan; J K Kelly
Journal:  J Hepatol       Date:  1987-08       Impact factor: 25.083

4.  Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; K Fleming; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

5.  Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis.

Authors:  T L Whiteside; S Lasky; L Si; D H Van Thiel
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

Review 6.  Recent advances in the management of primary sclerosing cholangitis.

Authors:  K D Lindor; R H Wiesner; N F LaRusso
Journal:  Semin Liver Dis       Date:  1987-11       Impact factor: 6.115

7.  Activation of the complement system in primary sclerosing cholangitis.

Authors:  G Senaldi; P T Donaldson; S Magrin; J M Farrant; G J Alexander; D Vergani; R Williams
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

8.  Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

Authors:  R W Chapman; P M Kelly; A Heryet; D P Jewell; K A Fleming
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

9.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Lymphocyte subsets in primary sclerosing cholangitis.

Authors:  K D Lindor; R H Wiesner; J A Katzmann; N F LaRusso; S J Beaver
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199
View more
  8 in total

1.  Genetics of inflammatory bowel disease.

Authors:  J Satsangi; D P Jewell; W M Rosenberg; J I Bell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

2.  Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.

Authors:  A Forbes; C Blanshard; B Gazzard
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

3.  Sclerosing cholangitis, race and sex.

Authors:  P Kelly; S Patchett; D McCloskey; E Alstead; M Farthing; P Fairclough
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 4.  The genetic jigsaw of inflammatory bowel disease.

Authors:  D A Watts; J Satsangi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.

Authors:  Allister J Grant; Sarah Goddard; Jalal Ahmed-Choudhury; Gary Reynolds; David G Jackson; Michael Briskin; Lijun Wu; Stefan G Hübscher; David H Adams
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Acquired Immune Deficiency Syndrome Cholangiopathy: Case Series of Three Patients and Literature Review.

Authors:  Yasir Ahmed; Mustafeez Ur Rahman; Zoia Ehsan Khattak; Jorge Herrera; Eduardo Calderon
Journal:  J Med Cases       Date:  2022-09-28

7.  Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis.

Authors:  Alex Frydrychowicz; Andrzej R Jedynak; Frederick Kelcz; Scott K Nagle; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

8.  Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

Authors:  Bertus Eksteen; Allister J Grant; Alice Miles; Stuart M Curbishley; Patricia F Lalor; Stefan G Hübscher; Michael Briskin; Mike Salmon; David H Adams
Journal:  J Exp Med       Date:  2004-11-22       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.